Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel vulnerability in melanoma. Meant A, Moussa O, Lebeau B, Goncalves C, et al. J Invest Dermatol 2024 Sep 30:S0022-202X(24)02160.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meant A, Moussa O, Lebeau B, Goncalves C, et al. Combined inhibition of MNK signaling and BET proteins reveals TGM2 as a novel vulnerability in melanoma. J Invest Dermatol 2024 Sep 30:S0022-202X(24)02160.
PMID: 39357785